NCT01924429View on ClinicalTrials.gov

Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
ADHD
Interventions
DRUG

Lisdexamfetamine

Escalating stepped dose titration: 30, 50 or 70mg

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Jeffrey Newcorn

OTHER

NCT01924429 - Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation | Biotech Hunter | Biotech Hunter